Patents
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
12/2002
12/31/2002US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
12/27/2002WO2002102380A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
12/27/2002CA2429113A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
12/24/2002US6497886 1,3-bis-(N-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/19/2002WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002US20020193449 Lactam compounds for penetration enhancement
12/19/2002CA2447687A1 Substituted 1-benzazepines and derivatives thereof
12/18/2002EP1265868A2 Dibenzo (b,f) azepine intermediates
12/18/2002EP1114026B1 Method for simultaneously producing a cyclic lactam and a cyclic amine
12/18/2002CN1386118A Lactams substituted by cyclic succinates as inhibitors of A beta protein production
12/17/2002US6495544 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
12/17/2002US6495541 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/17/2002US6495540 Lactams as inhibitors of A-β protein production
12/17/2002CA2153340C Application of riluzole in the treatment of parkinson's desease and parkinsonian syndromes
12/12/2002WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/11/2002EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002EP0984943B1 Azacyclooctane and heptane derivatives, their preparation and usein therapy
12/11/2002EP0628030B1 2,3,4,5-TETRAHYDRO-1H --3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF $g(a)-SUBSTITUTED-ARYLACETAMIDES
12/11/2002CN1384743A Remedies or preventives for diseases in association with chemokines
12/05/2002WO2002096881A1 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide
12/05/2002WO2001093840A2 Ligands of integrin receptors
12/05/2002US20020183515 Asymmetric synthesis of a key intermediate for making benazepril and analogues thereof
12/05/2002US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
12/05/2002US20020183324 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
12/05/2002DE10223968A1 Purification of N-vinyl-epsilon-caprolactam, used in production of (co)polymers used in cosmetics, pharmaceuticals and food technology and for coating fiber optics, involves partial crystallization from melt
12/05/2002CA2750876A1 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 5-carboxamide
12/05/2002CA2411549A1 Ligands of integrin receptors
12/04/2002EP1261580A1 Method for separating an azepine derivative out of a mixture containing an amine and an azepine derivative
12/03/2002US6489352 Antiepileptic agents; nervous system disorders
11/2002
11/28/2002WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002WO2002094787A1 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders
11/28/2002WO2002094176A2 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments
11/28/2002WO2002064557A9 New crystal forms of oxcarbazepine and processes for their preparation
11/28/2002CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002CA2447598A1 Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
11/27/2002EP0777492A4 Combinatorial libraries of substrate-bound cyclic organic compounds
11/27/2002CN1382126A Bleach boosting components, compositions and laundry methods
11/27/2002CN1382125A Bicycle vasporession agonists
11/26/2002US6486315 Recrystallization processes
11/21/2002WO2002092597A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.0?2,11.04.9¿)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002WO2002092572A1 Method for preparation of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide
11/21/2002WO2002092089A1 Tartrate salts of 5,8,14-triazatetracyclo {10.3.1.0?2,11.04,9¿}-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002US20020173504 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting B-amyloid peptide release and/or its synthesis by use of such compounds
11/21/2002CA2446988A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.02,11.04.9)-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/20/2002EP1257541A2 Polypharmacophoric agents
11/20/2002EP0593603B1 Bicyclic fibrinogen antagonists
11/19/2002US6482945 Evaporating mixture of cyclohexanone oxime and a solvent by introducing mixture into a fluidized bed in which inert particles is fluidized by inert gas, gas phase beckmann rearrangement reaction using a solid catalyst
11/19/2002US6482820 Benzazepine-n-acetic acid derivatives which contain an oxo-group in the alpha- position to the nitrogen atom and are substituted in position 3 by a 1-(carboxyalkyl)cyclo-entylcarbonylamino radical
11/19/2002US6482297 Method for distilling ammonia
11/19/2002CA2244021C Quaternary substituted bleach activators
11/19/2002CA2138308C Preparation of hexahydroazepinones and hexahydroazepinoles
11/15/2002WO2001096294A1 Method for the production of caprolactam
11/15/2002WO2001094308A1 Method for separating ammonia from solutions containing caprolactam and ammonia
11/15/2002CA2409357A1 Method for the production of caprolactam
11/14/2002WO2002089810A1 Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof
11/14/2002WO2002089803A1 Composition for iontophoresis
11/14/2002WO2002089800A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/14/2002US20020169156 Azacyclooctane and heptane derivatives, their preparation and use in therapy
11/12/2002US6479658 Method for cyclizing hydrolysis of an aminonitrile compound into lactam
11/07/2002WO2002088298A1 Compounds, compositions, and methods for controlling biofilms
11/07/2002CA2445591A1 Nitrogen heterocyclic compounds and compositions for controlling biofilms
11/06/2002EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002CN1378522A Process for treating mixture comprising ammonium sulfate solution and aqeous lactam phase
11/06/2002CN1093856C Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
11/05/2002US6476221 Tribenzazepine compound and production method thereof
10/2002
10/31/2002WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002WO2002069895A3 Heterocyclic analgesic compounds and methods of use thereof
10/31/2002WO2002043713A3 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence
10/30/2002WO2001083444A1 Method for producing cyclic lactams
10/30/2002CA2407813A1 Method for producing cyclic lactams
10/29/2002WO2001083443A1 Method for producing caprolactam on the basis of 6-aminocapronitrile and subsequent purification by crystallization
10/29/2002WO2001083442A1 Method for producing caprolactam from 6-aminocapronitrile
10/29/2002US6472540 Process for producing ε-caprolactone
10/29/2002US6472529 Viricides
10/29/2002CA2407728A1 Method for producing caprolactam on the basis of 6-aminocapronitrile and subsequent purification by crystallization
10/29/2002CA2407723A1 Method for producing caprolactam from 6-aminocapronitrile
10/24/2002WO2002083646A1 Lactam compounds for penetration enhancement
10/24/2002WO2002083635A1 PROCESS FOR THE PREPARTION OF ε-CAPROLACTAM
10/24/2002WO2002083630A1 Oxalic acid derivatives
10/24/2002WO2002083133A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants
10/24/2002WO2002064557A3 New crystal forms of oxcarbazepine and processes for their preparation
10/24/2002US20020156052 Tricyclic opiod receptor agonists
10/24/2002CA2445538A1 Oxalic acid derivatives
10/24/2002CA2443906A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants
10/23/2002EP1251122A1 Process for the preparation of epsilon-Caprolactam
10/23/2002EP1000067B1 Thiazolobenzoheterocycles, preparation and medicines containing same
10/22/2002US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002US6468996 Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
10/17/2002WO2002081448A1 Benzamidine derivative
10/17/2002US20020151571 Activity against arthropods in agriculture and parasites encountered in animal husbandry
10/17/2002US20020151545 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and metastasis inhibitors in treating cancer
10/17/2002US20020151538 Azepin-2-one derivatives useful for treating Alzheimer's disease
10/17/2002DE10117823A1 New N-phenyl-oxalamide derivatives, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, angina pectoris or tumor diseases
10/17/2002CA2442904A1 Benzamidine derivative
10/16/2002EP1248777A2 Tricyclic compounds with antiviral activity
10/16/2002CN1374960A Novel integrain receptor antagonists
10/10/2002WO2002053516A3 N(phenylsulphonyl)glycine derivatives and their therapeutic use
10/10/2002US20020147188 Protease inhibitors
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 88